Camden Partners

Catalyte, Inc. is a technology services company based in Baltimore, Maryland, specializing in information technology outsourcing, consulting, and managed services. Founded in 2000, the company focuses on workforce development and utilizes artificial intelligence to identify and cultivate high-potential talent, which is then integrated into client organizations. Catalyte offers a range of services including software engineering, application modernization, cloud and mobile development, and quality assurance. It also provides apprenticeship programs that allow individuals to gain practical experience while helping clients address their project needs. With development centers in cities such as Boston, Chicago, Englewood, and Portland, Catalyte aims to enhance productivity, quality, and diversity in the workforce through its innovative talent deployment strategies.

Thrive Earlier Detection Corp. is a healthcare company that specializes in developing advanced blood testing technologies for early cancer detection. Its flagship product, CancerSEEK, is a liquid biopsy test that analyzes genomic mutations in tumor DNA and protein markers in plasma, allowing for the identification of various cancers at their nascent stages, often before symptoms manifest. Founded in 2018 and headquartered in Cambridge, Massachusetts, with an additional office in Baltimore, Maryland, Thrive aims to integrate cancer screening into standard medical practice. The company leverages real-world data and machine learning to enhance the accuracy of cancer detection, facilitate follow-up testing, and streamline the transition to oncological care. Thrive operates as a subsidiary of Exact Sciences Corporation and has received investments from notable firms including Third Rock Ventures and Section 32.

Paragon Bioservices is an industry-leading, private-equity backed contract development and manufacturing organization (CDMO) whose focus is the development and manufacturing of cutting-edge biopharmaceuticals. Paragon aims to build strong client partnerships with the world’s best biotech and pharma companies, focusing on transformative technologies, including gene therapies (AAV), next-generation vaccines, oncology immunotherapies (oncolytic viruses and CAR-T cell therapies), therapeutic proteins, and other complex biologics. The Company’s customer base has also transitioned from primarily substantial government contracts to now focus almost 100% on commercial activity servicing the biotech marketplace. The Company has retained Paragon’s core scientific talent while expanding its leadership team with new key senior hires who have a proven track record in GMP manufacturing. Each member of the current leadership team has over 20 years of industry experience and serves as the Company’s foundation to build a dominant CDMO in Maryland. Paragon now provides complete manufacturing services from process development and clinical manufacturing through commercial launch at its new 150,000 ft2 facility.

Calvert Learning offers a comprehensive homeschool curriculum that combines traditional textbooks with online learning, serving English-speaking students from pre-kindergarten to eighth grade worldwide. The curriculum covers a wide range of subjects, including history, mathematics, science, literature, and foreign languages, as well as various enrichment programs in arts, music, and writing. Founded in 1906 and based in Hunt Valley, Maryland, Calvert Learning has a long history of providing educational resources for nontraditional learning environments. The company operates as a subsidiary of Edmentum, Inc. and focuses on delivering high-quality educational experiences through a flexible, modular approach tailored to the needs of schools and districts. Additionally, Calvert Learning provides advisory teaching and technical support services to enhance learning outcomes for students.